Bookmark

Add to MyYahoo RSS

Scios News

News on Scios (Ticker: JNJ) continually updated from thousands of sources around the net.

Tuesday Aug 26 | Bioscience Technology

Vivus acquires patent rights to Qsymia ingredient

Vivus has acquired a group of patents covering one of the main ingredients behind its weight loss drug Qsymia from Janssen Pharmaceuticals.

Comment?

Related Topix: Startups, VIVUS, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Tuesday Aug 26 | WebWire

ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.

ViaCyte, Inc., a privately held regenerative medicine company announced that it has entered into a Rights Agreement with Janssen Research & Development LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Mon Aug 25, 2014

GuruFocus.com

Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs

Johnson & Johnson is appreciating a decent time in 2014, liking 10% and beating the more extensive market so far.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Mon Aug 18, 2014

The Motley Fool

3 Reasons Johnson & Johnson Stock Could Rise

For the quarter, Johnson & Johnson delivered impressive revenue growth of 9.1% year-over-year.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Wed Aug 13, 2014

ThinkProgress

Check Your Mental Health With Just A Press Of A Button

Philadelphia residents can now check their mental health in the grocery store, thanks to an interactive screening kiosk known as "Checkup and Checkout" that officials unveiled earlier this month.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Fri Aug 08, 2014

Connecticut Post

Hysterectomy tool creates cancer fears

About 600,000 hysterectomies are performed in the U.S. each year. Research suggests about 40% are done to remove presumably benign or noncancerous fibroids that are causing heavy bleeding, pelvic pressure or pain or other symptoms Power morcellators, like the one below, are used in this procedure, are under scrutiny.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Mon Aug 04, 2014

Outpatient Surgery Magazine

Johnson & Johnson Asks Customers to Return Morcellators

As the polarized debate regarding the safety and desirability of power morcellation in minimally invasive hysterectomies continues to rage, Johnson & Johnson, easily the largest manufacturer of laparoscopic morcellators, has announced that it's withdrawing the device from the market.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Thu Jul 31, 2014

Wall Street Journal

Johnson & Johnson Partners with CircleUp for Early Look at Startups

CircleUp COO Rory Eakin and CEO Ryan Caldbeck with an array of products made by companies that raised equity funding on their site.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

The Jersey Journal

Johnson & Johnson withdraws controversial hysterectomy tool from market

Howard Schwartz looks at a photo of his wife, Sandra Brown, who died last December.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Wed Jul 30, 2014

USA Today

Hysterectomy device pulled off market

Hysterectomy device pulled off market Johnson & Johnson announces worldwide withdrawal of all its laparoscopic power morcellators.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••